CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT03095040 · UNKNOWN

Trial details

NCT number: NCT03095040
Sponsor: AnewPharma
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Cell Cancer Metastatic

Start date: 2016-12-16
Primary completion: 2021-02-01
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.